| Trial ID: | L3437 |
| Source ID: | NCT00441363
|
| Associated Drug: |
Bromocriptine Mesylate
|
| Title: |
Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00441363/results
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Bromocriptine Mesylate
|
| Outcome Measures: |
Primary: Change in Baseline to End of Study in HbA1c, Too few subjects were enrolled to assess outcome to pre-specified statistical power., up to 24 weeks | Secondary: Fasting Plasma Glucose and Lipids, up to 24 weeks|Number of Serious Adverse Events Experienced by the Subjects, up to 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: VeroScience
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
66
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2005-02
|
| Completion Date: |
2006-03
|
| Results First Posted: |
2016-05-09
|
| Last Update Posted: |
2016-05-09
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00441363
|
